Key result
L-arginine ameliorated adverse cardiovascular effects of hypertension in aged spontaneously hypertensive rats, reducing arterial pressure, left ventricular mass, and collagen content.
Why the study?
Does L-arginine improve coronary hemodynamics and reduce cardiac fibrosis in aged spontaneously hypertensive and normotensive rats?
Does L-arginine improve coronary hemodynamics and reduce cardiac fibrosis in aged spontaneously hypertensive and normotensive rats?
Answers are grounded in this paper and cite their sources.
Prolonged L-arginine supplementation ameliorates the adverse cardiovascular effects of hypertension, including cardiac hypertrophy and fibrosis, in aged spontaneously hypertensive rats.
This study was designed to examine whether L-arginine could prevent hypertension- and age-related impairment of coronary hemodynamics and cardiac fibrosis in aged (80-week-old) rats. To differentiate between hypertension- and age-related changes, the study was performed in both normotensive Wistar-Kyoto rats (WKYs) and spontaneously hypertensive rats (SHR). Male 1-year-old rats of both strains were divided into 2 groups and given either placebo or L-arginine (1.2 g/L) in drinking water. After 6 months, systemic and coronary hemodynamics (radionuclide-labeled microspheres), right and left ventricular and aortic mass indexes, and ventricular hydroxyproline (an estimate of collagen) concentrations were determined. In the aged WKYs, L-arginine did not affect any of the examined variables except slightly reducing total peripheral resistance. In contrast, L-arginine diminished arterial pressure, total peripheral resistance, and left ventricular and aortic mass indexes in the SHRs; it also increased coronary flow reserve and reduced minimal coronary flow resistance and myocardial hydroxyproline concentration. These findings demonstrated that L-arginine ameliorated adverse cardiovascular effects of hypertension in aged SHRs, as demonstrated by reduced arterial pressure and total peripheral resistance, diminished left ventricular mass and collagen content, and improved coronary hemodynamics. There were no important effects in the old WKYs.
No takes yet. Share an insight, caveat, or question.
Sušić et al. (1999) studied Hypertension. L-arginine vs. Placebo was evaluated on Systemic and coronary hemodynamics, ventricular and aortic mass indexes, and ventricular hydroxyproline concentrations. L-arginine ameliorated adverse cardiovascular effects of hypertension in aged spontaneously hypertensive rats, reducing arterial pressure, left ventricular mass, and collagen content.
Synapse has enriched 10 related papers. Consider them for comparative context: